Bio-Techne
TECH
$92.41
Share price
-5.72%
Change (1 day)
-17.03%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Revenue for Bio-Techne (TECH)
Revenue in 2024 (TTM): NZ$1.99 Billion
According to Bio-Techne's latest financial reports the company's current revenue (TTM 
) is NZ$2.13 Billion. an increase over the revenue in the year 2023 that were of NZ$1.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bio-Techne from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$2.12 B | 17.13% |
| 2023 | NZ$1.81 B | 2.65% |
| 2022 | NZ$1.76 B | 17.01% |
| 2021 | NZ$1.50 B | 36.13% |
| 2020 | NZ$1.10 B | 0.14% |
| 2019 | NZ$1.10 B | 8.8% |
| 2018 | NZ$1.01 B | 20.42% |
| 2017 | NZ$0.84 B | 10.69% |
| 2016 | NZ$0.76 B | 12.19% |
| 2015 | NZ$0.67 B | 30.34% |
| 2014 | NZ$0.52 B | 29.77% |
| 2013 | NZ$0.40 B | 5.79% |
| 2012 | NZ$0.37 B | -3.32% |
| 2011 | NZ$0.39 B | 11.15% |
| 2010 | NZ$0.35 B | -3.07% |
| 2009 | NZ$0.36 B | -21.2% |
| 2008 | NZ$0.46 B | 48.44% |
| 2007 | NZ$0.31 B | 3.71% |
| 2006 | NZ$0.30 B | 7.43% |
| 2005 | NZ$0.27 B | 18.71% |
| 2004 | NZ$0.23 B | -0.14% |
| 2003 | NZ$0.23 B | -10.35% |
| 2002 | NZ$0.26 B | -10.35% |
| 2001 | NZ$0.29 B | 19.92% |
| 2000 | NZ$0.24 B | 30.8% |
| 1999 | NZ$0.18 B | 24.71% |
| 1998 | NZ$0.15 B | 37.17% |
| 1997 | NZ$0.10 B | 33.99% |
| 1996 | NZ$81.67 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | NZ$76.61 B | 3,485.15% | 🇺🇸 USA |
 | NZ$4.58 B | 114.59% | 🇺🇸 USA |
 | NZ$36.87 B | 1,625.73% | 🇺🇸 USA |
 | NZ$42.65 B | 1,896.21% | 🇺🇸 USA |
 | NZ$3.51 B | 64.39% | 🇳🇱 Netherlands |
 | NZ$81.82 B | 3,729.30% | 🇺🇸 USA |
 | NZ$51.98 M | -97.57% | 🇺🇸 USA |